ISO 22367 specifies a process for a medical laboratory to identify and manage the risk to patients and service providers that are associated with medical laboratory examinations.
Research Excellence Awards are awarded each year to top-ranked researchers and teams following peer review of applications to the NHMRC's highly competitive grant schemes.
Thermo Fisher Scientific has proposed to acquire QIAGEN and appointed Paul G Parker as Senior Vice President, Strategy and Corporate Development.
The STEM Ambassador Program encourages the involvement of science in Australian politics and aims to put science and evidence-based policy on the national agenda.
Metrohm Australia has announced that, as of 1 March 2020, it is the exclusive distributor for ELGA LabWater in Australia for the PURELAB and CENTRA ranges.
The Australian Academy of Science has presented its prestigious 2020 honorific awards to 18 different researchers for their outstanding contributions to science.
With major audits conducted in laboratories every two to four years, assessors are tasked with checking all necessary documentation to ensure accreditation is maintained.
Trajan Nutrition has signed an MOU with the South Australian Health and Medical Research Institute to accelerate the translation in the global market of nutrition testing research.
Professor Lisa Kewley has been awarded the 2020 James Craig Watson Medal by the US National Academy of Sciences for her contributions to the study of galaxy formation and evolution.
Caplacizumab is said to be the first nanobody therapy to treat adults with the rare autoimmune blood-clotting disorder known as acquired thrombotic thrombocytopenic purpura.
Scientists have created a roadmap to insect conservation and recovery, based on achieving targets over different timescales.
Abcam has announced the successful completion of the acquisition of Expedeon's Proteomics and Immunology business, which includes Innova and TGR Biosciences, as of 1 January 2020.
ISO 35001 defines the requirements and guidance for laboratories or any other organisation that works with biological agents to control and reduce any risks associated with their use.
Novartis is offering a US$250,000 prize to fund development of pioneering innovation with great potential in advancing assistive tech for multiple sclerosis (MS).